Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Medtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success was offset by weaker sales from its medical-surgical business.

Medtronic and Abbott Labs have raised their dividends for a combined 99 years. Both healthcare giants have solid operations and excellent long-term prospects. What makes an outstanding dividend stock?

Medtronic plc MDT reported adjusted earnings per share (EPS) of $1.39 for the third quarter fiscal of 2025, up 6.9% from the year-ago quarter’s figure. The figure also beat the Zacks Consensus ...